Primary targets of treatment in the Division of Nephrology include edema, hematuria, proteinuria, acid-base and electrolyte abnormality, glomerular disease, interstitial nephritis, acute kidney injury, chronic kidney disease, kidney disease due to diabetes and hypertension, and renal hypertension. We treat end stage kidney failure (ESKF) patients with conservative therapy or through hemodialysis, peritoneal dialysis, and kidney transplantation. Today, the number of patients suffering from kidney diseases is at a stark increase due to an increase in hypertension, diabetes, and obesity. The number of (ESKF) patients receiving dialysis or living with transplanted kidney is also rapidly increasing.
Our center has the best quality of medical service in various glomerulonephritis such as IgA nephropathy, minimal change disease (MCD), membranous nephritis, focal segmental glomerulosclerosis (FSGS) and also in rare and intractable diseases such as lupus nephritis, hemolytic uremic syndrome, and polycystic kidney disease (PKD).
We provide hemodialysis treatment in the in-patient and out-patient basis and continuous renal replacement therapy (CRRT) for critically ill patients. We are also proud of the peritoneal dialysis (PD) unit, having treated over 1,300 patients on PD cumulatively with the best treatment outcomes in the world. Our kidney clinic provides monthly patient education program, when medical information and education is given in the area of the kidney disease itself, diet, drug therapy, dialysis, and transplantation therapy for patients with chronic kidney disease.
In addition, Urgent Nephrology Care Clinic (UNCC) provides routine doppler ultrasound evaluation for arterio-venous fistula regularly from hemodialysis patients. Nephrology One-day Admission Ward provides prophylaxis against contrast-induced nephropathy during contrast administration from patients with reduced kidney function as a one-stop service. We are proud of our 40-years of experience in kidney transplantation in our institution and accompanying superior outcomes in both patient and graft survival. A multidisciplinary approach based on cutting- edge knowledge may contribute to providing elaborate care to both the recipients and donors.